Abstract Details

Title Cellular and Humoral Influenza Vaccine-Specific Immune Responses in Patients with Multiple Sclerosis Treated with FTY720 or Interferon-beta

Topic MS and Related Diseases

Presentation(s) (-)

Poster/Presentation
Number 217

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Matthias Mehling, MD (Neurology Clinic University Hospital Basel/Switzerland)	The institution of Dr. Mehling has received research support from Swiss National Science Foundation. The institution of Dr. Mehling has received research support from Roche. The institution of Dr. Mehling has received research support from Merck.
	No disclosure on file
	No disclosure on file
Raija Lindberg, MD	No disclosure on file
Jens Kuhle, MD	Dr. Kuhle has nothing to disclose.
	No disclosure on file
Jennifer Graves, MD, PhD (UCSD)	Dr. Graves has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Graves has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Graves has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MSJ. The institution of Dr. Graves has received research support from Octave. The institution of Dr. Graves has received research support from Sanofi. The institution of Dr. Graves has received research support from EMD Serono.

��ɫ��